For the readers interested in the stock health of Stealth BioTherapeutics Corp (MITO). It is currently valued at $1.49. When the transactions were called off in the previous session, Stock hit the highs of $1.57, after setting-off with the price of $1.30. Company’s stock value dipped to $1.291 during the trading on the day. When the trading was stopped its value was $1.30.
Recently in News on December 7, 2020, Stealth BioTherapeutics Announces Appointment of Eve E. Slater, M.D., F.A.C.C. to its Board of Directors. Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced the appointment of Eve E. Slater, M.D., F.A.C.C., to the Company’s Board of Directors. Dr. Slater is board certified in internal medicine and cardiology and brings considerable experience from the pharmaceutical industry. Dr. Slater has served as Senior Vice President for Worldwide Policy, Pfizer, Inc., Assistant Secretary for Health in the US Department of Human Services, and Senior Vice President of Clinical and Regulatory Development, and SVP of External Policy of Merck and Co. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Stealth BioTherapeutics Corp had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.0000 on 03/03/20, with the lowest value was $0.9002 for the same time period, recorded on 03/18/20.
Stealth BioTherapeutics Corp (MITO) full year performance was -87.35%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Stealth BioTherapeutics Corp shares are logging -89.66% during the 52-week period from high price, and 65.52% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.90 and $14.41.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 6256098 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Stealth BioTherapeutics Corp (MITO) recorded performance in the market was -54.29%, having the revenues showcasing -1.57% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 78.63M, as it employees total of 73 workers.
Analysts verdict on Stealth BioTherapeutics Corp (MITO)
During the last month, 1 analysts gave the Stealth BioTherapeutics Corp a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.5408, with a change in the price was noted -0.3200. In a similar fashion, Stealth BioTherapeutics Corp posted a movement of -17.68% for the period of last 100 days, recording 203,504 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for MITO is recording 3.91 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Stealth BioTherapeutics Corp (MITO): Technical Analysis
Raw Stochastic average of Stealth BioTherapeutics Corp in the period of last 50 days is set at 76.92%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 75.00%. In the last 20 days, the company’s Stochastic %K was 45.37% and its Stochastic %D was recorded 36.73%.
Let’s take a glance in the erstwhile performances of Stealth BioTherapeutics Corp, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -54.29%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -31.89%, alongside a downfall of -87.35% for the period of the last 12 months. The shares increased approximately by 9.56% in the 7-day charts and went down by 11.19% in the period of the last 30 days. Common stock shares were lifted by -1.57% during last recorded quarter.